On June 30, 2025, Yasushi Nagasaki resigned as Chief Financial Officer of Emmaus Life Sciences, transitioning to full retirement, with Hiroko Huynh promoted to Chief Accounting Officer effective July 1, 2025. Huynh has been with Emmaus since January 2020 and previously worked at Deloitte & Touche LLP.